CRMSX
Price
$15.31
Change
+$0.03 (+0.20%)
Updated
Jul 31 closing price
Net Assets
73.2M
VSCPX
Price
$408.08
Change
-$0.97 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

CRMSX vs VSCPX

CRMSX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
CRMSX vs. VSCPX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMSX is a Hold and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 189B vs. CRMSX (73.2M). VSCPX pays higher dividends than CRMSX: VSCPX (1.24) vs CRMSX (0.83). CRMSX was incepted earlier than VSCPX: CRMSX (31 years) vs VSCPX (16 years). CRMSX (1.31) is less costly to investors than VSCPX (0.02). CRMSX is a more actively managed with annual turnover of: 38.00 vs. VSCPX (17.00). CRMSX has a lower initial minimum investment than VSCPX: CRMSX (2500) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 22.59 vs. CRMSX (19.94). VSCPX return over 5 years is better than : 35.15 vs. CRMSX (-6.12).
CRMSXVSCPXCRMSX / VSCPX
Total Expense Ratio1.310.026,550%
Annual Report Gross Expense Ratio1.310.026,550%
Fund Existence31 years16 years-
Gain YTD19.79714.596136%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets73.2M189B0%
Annual Yield % from dividends0.831.2467%
Returns for 1 year19.9422.5988%
Returns for 3 years19.8543.4546%
Returns for 5 years-6.1235.15-17%
Returns for 10 years-0.38156.12-0%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFANX14.840.01
+0.07%
Fidelity Asset Manager 40%
EPSPX29.64-0.04
-0.13%
NYLI Epoch Global Equity Yield Class A
MSOIX38.48-0.14
-0.36%
NYLI WMC Enduring Capital Class I
GAGCX38.69-0.17
-0.44%
Gabelli Global Rising Income and Div AAA
MRSRX28.14-0.17
-0.60%
MFS Research International R2